🇺🇸 FDA
Pipeline program

Sinovac PCV24 formulation 1

PRO-PCV24-1002

Phase 1 mab completed

Quick answer

Sinovac PCV24 formulation 1 for Pneumococcal Infectious Disease is a Phase 1 program (mab) at SINOVAC BIOTECH LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Pneumococcal Infectious Disease
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials